Simulations Plus Faces Legal Probe After Guidance Cut and $77M Asset Impairment

Key Facts

1Johnson Fistel has launched an investigation into potential securities law violations by Simulations Plus.

2The investigation follows a revenue guidance cut, a $77.2 million impairment charge, and a dispute with auditors.

In a move reflecting heightened regulatory scrutiny on companies facing financial reporting setbacks, Johnson Fistel has launched an investigation into potential securities law violations by Simulations Plus. The probe follows the company's decision to cut its revenue guidance and recognize a substantial $77.2 million impairment charge. According to reports, the investigation also targets a dispute with auditors regarding internal accounting controls.

This crisis emerges at a sensitive time for the pharmaceutical simulation software sector, where investors are closely monitoring margin sustainability. In comparison to peers, Certara (CERT) reported a 7% revenue growth in its latest quarter per its earnings release, placing Simulations Plus's performance under further scrutiny. Legal experts cited by Newsfile Corp suggest that such investigations typically follow sharp downward revisions in financial outlooks to ensure shareholder protection against misleading statements.

Traders should watch key support levels for SLP stock, which closed at $15.91 on June 8, 2026, after trading between a high of $16.12 and a low of $15.64 per market data. Looking ahead, broader market sentiment in the tech sector may be influenced by the upcoming U.S. Initial Jobless Claims data, which could impact risk appetite for mid-cap stocks.